Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference

Wednesday, August 9, 2023 at 8:30 am Eastern Time REDWOOD CITY, Calif., July 12, 2023 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Kevin Thornal,…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks